Japan approves regenerative stem cell therapies

Claim

Japan approved first-of-their-kind regenerative stem cell therapies for Parkinson's disease and severe heart failure, while Spanish researchers found p-tau217 blood tests raise Alzheimer's diagnostic accuracy from 75.5% to 94.5%.

Reported metric: 75.5% → 94.5%

Reporting date: 2026-02-24 (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

• Welcome to February 24, 2026 (theinnermostloop.substack.com)